Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-valvular Atrial Fibrillation (NVAF)”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT03993119
What this trial is testing

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 500
Not applicableStudy completedNCT04234698
What this trial is testing

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Who this might be right for
Atrial Fibrillation
Pfizer 2,076
Not applicableNot Yet RecruitingNCT07396493
What this trial is testing

A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)High Risk of Stroke
Shanghai Zhongshan Hospital 306
Not applicableActive Not RecruitingNCT05038228
What this trial is testing

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Who this might be right for
Atrial Fibrillation
Pfizer 1
Not applicableStudy completedNCT02674594
What this trial is testing

Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US

Who this might be right for
Nonvalvular Atrial Fibrillation
Bristol-Myers Squibb 30,000
Not applicableEnded earlyNCT06189365
What this trial is testing

Amplatzer Amulet China Post Market Study (PMS)

Who this might be right for
Non-Valvular Atrial Fibrillation
Abbott Medical Devices 50
Not applicableLooking for participantsNCT04298723
What this trial is testing

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Who this might be right for
Intracranial HemorrhagesAtrial Fibrillation (AF)Atrial Flutter
Jena University Hospital 530
Not applicableStudy completedNCT04722679
What this trial is testing

Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.

Who this might be right for
Non-Valvular Atrial Fibrillation
Bayer 103
Not applicableWithdrawnNCT05116267
What this trial is testing

Assessment of the Effectiveness and Safety Outcome in Patients With Atrial Fibrillation Treated by Apixaban in Belgium

Who this might be right for
Atrial Fibrillation
Pfizer
Not applicableStudy completedNCT05471505
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 120,722
Not applicableWithdrawnNCT04198844
What this trial is testing

The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study

Who this might be right for
Atrial Fibrillation
Pfizer
Not applicableStudy completedNCT04509193
What this trial is testing

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Who this might be right for
Atrial Fibrillation
Bayer 116,049
Not applicableStudy completedNCT04099238
What this trial is testing

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Who this might be right for
Atrial Fibrillation
Bayer 3,739
Not applicableStudy completedNCT05022758
What this trial is testing

Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 45,000
Not applicableStudy completedNCT02485873
What this trial is testing

Real-Life Evidence on Stroke Prevention in SPAF

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)
Bayer 8,607
Not applicableStudy completedNCT03247569
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company 300
Not applicableUnknownNCT04476147
What this trial is testing

The Impact of Frailty on Thrombosis of Elderly Patients With NVAF （FTE-NVAF）

Who this might be right for
Non-valvular Atrial Fibrillation, Elderly, Frailty, Thrombosis
Beijing Friendship Hospital 500
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableStudy completedNCT03887780
What this trial is testing

Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 504
Not applicableStudy completedNCT04174859
What this trial is testing

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Who this might be right for
Non-valvular Atrial Fibrillation
Bayer 812
Load More Results